סך נכסי הפעילות העסקית Incannex Healthcare Ltd (IXHL)

The price history of Incannex Healthcare (IXHL) shares on GURU.Markets, where total assets amount to 46.71, highlights raw material devaluation risks and pressure from industry behemoths. Incannex Healthcare focuses on developing cutting-edge psychedelic and cannabinoid-based medicines for the treatment of TBI and apnea. Additionally, the business is accelerating clinical trials for IHL-42X, seeking FDA approval for the treatment of PTSD.

This metric, reverse-calculated via return on assets (ROA), reflects the total volume of resources and liabilities, determining the actual scale of the business relative to its market capitalization. For Incannex Healthcare (IXHL), the trend in total assets demonstrates a financial base that supports the diversification of its drug portfolio for apnea and anxiety disorders, where resource growth confirms the company's ability to fund parallel clinical trials.